What is the cure rate for mid- to late-stage testicular cancer?

The cure rate of mid-to-late stage testicular cancer is relatively low compared to the early stage, but patients should not be discouraged. As long as the patients actively cooperate with the doctor for treatment and pay attention to postoperative care after treatment, mid-to-late stage testicular cancer can be cured. What is the cure rate of mid-to-late stage testicular cancer? The following is a detailed introduction.

DDP combined with chemotherapy is becoming more and more mature. The survival rate of patients with testicular germ cell cancer is constantly improving. The 3-year cancer-free overall survival rate has exceeded 80%. The cancer-free survival rate of patients with mild and moderate dissemination can reach more than 90%, but the survival rate of cases with extensive dissemination is still less than 50%. Patients with mild and moderate dissemination of testicular cancer have a good prognosis. The current research focus is on how to reduce the toxicity of chemotherapy. The commonly used method is to change 4 courses of chemotherapy to 3 courses or replace VLB with VP16, retain or cancel BLM, that is, replace the standard VPB regimen with PVP16 or PVP16B regimen, or replace DDP with carbon platinum (JM-8). The research direction of rescue chemotherapy for extensive dissemination of testicular cancer is mainly to find new combination drugs for DDP (such as ifosfamide), new chemotherapy regimens and high-dose DDP combined chemotherapy.

Testicular cancer mainly affects young men in their fertility peak, so it has a great impact on society. However, the cure rate of testicular cancer is very high, with a survival rate of 95% or even higher, so in the field of oncology, testicular cancer is a very important malignant tumor.

Testicular seminoma is sensitive to a variety of anti-tumor drugs. my country's first N-formyl sarcolytic agent is used to treat testicular seminoma. 150-200 mg is taken every night before bedtime, and 6-8 g is a course of treatment. The total effective rate is 91%, of which 2/3 are completely relieved. Recently, PVB or VAB-6, PVP16 combined chemotherapy is mainly used, and the cure rate of stage III cases is 90%.

The pathological type of testicular tumors is related to prognosis. The degree of tumor spread and the range of metastasis also affect the prognosis. Therefore, clinicians should not only understand the pathological type of the tumor, but also formulate corresponding treatment plans according to the different range of the lesions.